Association of large core middle cerebral artery stroke and hemorrhagic transformation with hospitalization outcomes.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
01 05 2024
Historique:
received: 28 07 2023
accepted: 25 04 2024
medline: 2 5 2024
pubmed: 2 5 2024
entrez: 1 5 2024
Statut: epublish

Résumé

Historically, investigators have not differentiated between patients with and without hemorrhagic transformation (HT) in large core ischemic stroke at risk for life-threatening mass effect (LTME) from cerebral edema. Our objective was to determine whether LTME occurs faster in those with HT compared to those without. We conducted a two-center retrospective study of patients with ≥ 1/2 MCA territory infarct between 2006 and 2021. We tested the association of time-to-LTME and HT subtype (parenchymal, petechial) using Cox regression, controlling for age, mean arterial pressure, glucose, tissue plasminogen activator, mechanical thrombectomy, National Institute of Health Stroke Scale, antiplatelets, anticoagulation, temperature, and stroke side. Secondary and exploratory outcomes included mass effect-related death, all-cause death, disposition, and decompressive hemicraniectomy. Of 840 patients, 358 (42.6%) had no HT, 403 (48.0%) patients had petechial HT, and 79 (9.4%) patients had parenchymal HT. LTME occurred in 317 (37.7%) and 100 (11.9%) had mass effect-related deaths. Parenchymal (HR 8.24, 95% CI 5.46-12.42, p < 0.01) and petechial HT (HR 2.47, 95% CI 1.92-3.17, p < 0.01) were significantly associated with time-to-LTME and mass effect-related death. Understanding different risk factors and sequelae of mass effect with and without HT is critical for informed clinical decisions.

Identifiants

pubmed: 38693282
doi: 10.1038/s41598-024-60635-0
pii: 10.1038/s41598-024-60635-0
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10008

Subventions

Organisme : NIH HHS
ID : R01 EY024019
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL092577
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS102574
Pays : United States
Organisme : NINDS NIH HHS
ID : K23NS116033
Pays : United States

Informations de copyright

© 2024. The Author(s).

Références

Wijdicks, E. F. et al. Recommendations for the management of cerebral and cerebellar infarction with swelling: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 45(4), 1222–1238 (2014).
pubmed: 24481970 doi: 10.1161/01.str.0000441965.15164.d6
Hacke, W. et al. “Malignant” middle cerebral artery territory infarction: Clinical course and prognostic signs. Arch. Neurol. 53(4), 309–315 (1996).
pubmed: 8929152 doi: 10.1001/archneur.1996.00550040037012
Yarbrough, C. K. et al. Endovascular thrombectomy for anterior circulation stroke: Systematic review and meta-analysis. Stroke 46(11), 3177–3183 (2015).
pubmed: 26396032 doi: 10.1161/STROKEAHA.115.009847
Wu, S. et al. Early prediction of malignant brain edema after ischemic stroke. Stroke 49(12), 2918–2927 (2018).
pubmed: 30571414 doi: 10.1161/STROKEAHA.118.022001
Miao, J. et al. Predictors of malignant cerebral edema in cerebral artery infarction: A meta-analysis. J. Neurol. Sci. 409, 116607 (2019).
pubmed: 31830611 doi: 10.1016/j.jns.2019.116607
Ong, C. J. et al. Enhanced detection of edema in malignant anterior circulation stroke (EDEMA) score: A risk prediction tool. Stroke 48(7), 1969–1972 (2017).
pubmed: 28487333 pmcid: 5487281 doi: 10.1161/STROKEAHA.117.016733
Ong, C. et al. New methods of natural language processing using machine learning methods to identify ischemic stroke presence, acuity, and location from clinical radiology reports. Mach. Learn. Healthc. https://doi.org/10.1371/journal.pone.0234908 (2019).
doi: 10.1371/journal.pone.0234908
Pullicino, P. M. et al. Mass effect and death from severe acute stroke. Neurology 49(4), 1090–1095 (1997).
pubmed: 9339695 doi: 10.1212/WNL.49.4.1090
Cheng, Y. et al. External validation and modification of the EDEMA score for predicting malignant brain edema after acute ischemic stroke. Neurocrit. Care 32(1), 104–112 (2020).
pubmed: 31549349 doi: 10.1007/s12028-019-00844-y
Kimberly, W. T. et al. Association of reperfusion with brain edema in patients with acute ischemic stroke: A secondary analysis of the MR CLEAN trial. JAMA Neurol. 75(4), 453–461 (2018).
pubmed: 29365017 pmcid: 5885187 doi: 10.1001/jamaneurol.2017.5162
Foroushani, H. M. et al. Quantitative serial CT imaging-derived features improve prediction of malignant cerebral edema after ischemic stroke. Neurocrit. Care 33(3), 785–792 (2020).
pubmed: 32729090 pmcid: 7738418 doi: 10.1007/s12028-020-01056-5
Guenego, A. et al. Hemorrhagic transformation after stroke: Inter- and intrarater agreement. Eur. J. Neurol. 26(3), 476–482 (2019).
pubmed: 30414302 doi: 10.1111/ene.13859
Li, J. et al. Stroke lateralization in large hemisphere infarctions: Characteristics, stroke-related complications, and outcomes. Front. Neurol. 12, 774247 (2021).
pubmed: 34956055 pmcid: 8702425 doi: 10.3389/fneur.2021.774247
Hacke, W. et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 352(9136), 1245–51 (1998).
pubmed: 9788453 doi: 10.1016/S0140-6736(98)08020-9
Thoren, M. et al. Effect of recanalization on cerebral edema in ischemic stroke treated with thrombolysis and/or endovascular therapy. Stroke 51(1), 216–223 (2020).
pubmed: 31818228 doi: 10.1161/STROKEAHA.119.026692
Yaghi, S. et al. Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: A scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 48(12), e343–e361 (2017).
pubmed: 29097489 doi: 10.1161/STR.0000000000000152
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B (Methodological) 57(1), 289–300 (1995).
doi: 10.1111/j.2517-6161.1995.tb02031.x
Chen, P. M. et al. Timing of symptomatic intracerebral hemorrhage after rt-PA treatment in ischemic stroke. Neurol. Clin. Pract. 9(4), 304–308 (2019).
pubmed: 31583184 pmcid: 6745738 doi: 10.1212/CPJ.0000000000000632
Berger, C. et al. Hemorrhagic transformation of ischemic brain tissue: Asymptomatic or symptomatic?. Stroke 32(6), 1330–1335 (2001).
pubmed: 11387495 doi: 10.1161/01.STR.32.6.1330
Fiorelli, M. et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: Relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 30(11), 2280–2284 (1999).
pubmed: 10548658 doi: 10.1161/01.STR.30.11.2280
Trouillas, P. & von Kummer, R. Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke. Stroke 37(2), 556–561 (2006).
pubmed: 16397182 doi: 10.1161/01.STR.0000196942.84707.71
Juttler, E. et al. DESTINY II: Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery II. Int. J. Stroke 6(1), 79–86 (2011).
pubmed: 21205246 doi: 10.1111/j.1747-4949.2010.00544.x
Juttler, E. et al. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): A randomized, controlled trial. Stroke 38(9), 2518–2525 (2007).
pubmed: 17690310 doi: 10.1161/STROKEAHA.107.485649
Vahedi, K. et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: A pooled analysis of three randomised controlled trials. Lancet Neurol. 6(3), 215–222 (2007).
pubmed: 17303527 doi: 10.1016/S1474-4422(07)70036-4
Hofmeijer, J. et al. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): A multicentre, open, randomised trial. Lancet Neurol. 8(4), 326–333 (2009).
pubmed: 19269254 doi: 10.1016/S1474-4422(09)70047-X
Larrue, V. et al. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: A secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 32(2), 438–441 (2001).
pubmed: 11157179 doi: 10.1161/01.STR.32.2.438
Marsh, E. B. et al. Predicting hemorrhagic transformation of acute ischemic stroke: Prospective validation of the HeRS score. Medicine (Baltimore) 95(2), e2430 (2016).
pubmed: 26765425 doi: 10.1097/MD.0000000000002430
Paciaroni, M. et al. Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke. Cerebrovasc. Dis. 28(2), 119–123 (2009).
pubmed: 19506370 doi: 10.1159/000223436
Zhang, G. et al. Hemoglobin A1c predicts hemorrhagic transformation and poor outcomes after acute anterior stroke. Eur. J. Neurol. 25(12), 1432-e122 (2018).
pubmed: 29959811 doi: 10.1111/ene.13747
Leira, R. et al. A higher body temperature is associated with haemorrhagic transformation in patients with acute stroke untreated with recombinant tissue-type plasminogen activator (rtPA). Clin. Sci. (Lond.) 122(3), 113–9 (2012).
pubmed: 21861843 doi: 10.1042/CS20110143
Rastogi, V. et al. Hemispheric differences in malignant middle cerebral artery stroke. J. Neurol. Sci. 353(1–2), 20–7 (2015).
pubmed: 25959980 doi: 10.1016/j.jns.2015.04.036
Nogueira, R. G. et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N. Engl. J. Med. 378(1), 11–21 (2018).
pubmed: 29129157 doi: 10.1056/NEJMoa1706442
Sarraj, A. et al. Trial of endovascular thrombectomy for large ischemic strokes. N. Engl. J. Med. 388(14), 1259–1271 (2023).
pubmed: 36762865 doi: 10.1056/NEJMoa2214403
Albers, G. W. et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N. Engl. J. Med. 378(8), 708–718 (2018).
pubmed: 29364767 pmcid: 6590673 doi: 10.1056/NEJMoa1713973
Acampa, M. et al. Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis. Int. J. Cardiol. 243, 466–470 (2017).
pubmed: 28747037 doi: 10.1016/j.ijcard.2017.03.129
Urakawa, M. et al. Blood-brain barrier disturbance following localized hyperthermia in rats. Int. J. Hyperthermia 11(5), 709–18 (1995).
pubmed: 7594821 doi: 10.3109/02656739509022502
Meyer, S. et al. Lateralization in autonomic dysfunction in ischemic stroke involving the insular cortex. Neuroreport 15(2), 357–61 (2004).
pubmed: 15076768 doi: 10.1097/00001756-200402090-00029
Yoon, B. W. et al. Cerebral hemispheric lateralization in cardiac autonomic control. Arch. Neurol. 54(6), 741–4 (1997).
pubmed: 9193209 doi: 10.1001/archneur.1997.00550180055012
Powers, W. J. et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 50(12), e344–e418 (2019).
pubmed: 31662037 doi: 10.1161/STR.0000000000000211
Juttler, E. et al. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. N. Engl. J. Med. 370(12), 1091–100 (2014).
pubmed: 24645942 doi: 10.1056/NEJMoa1311367
Huo, X. et al. Trial of endovascular therapy for acute ischemic stroke with large infarct. N. Engl. J. Med. 388(14), 1272–1283 (2023).
pubmed: 36762852 doi: 10.1056/NEJMoa2213379
Ropper, A. H. Lateral displacement of the brain and level of consciousness in patients with an acute hemispheral mass. N. Engl. J. Med. 314(15), 953–8 (1986).
pubmed: 3960059 doi: 10.1056/NEJM198604103141504
Demeestere, J. et al. Evaluation of hyperacute infarct volume using ASPECTS and brain CT perfusion core volume. Neurology 88(24), 2248–2253 (2017).
pubmed: 28515270 pmcid: 5567320 doi: 10.1212/WNL.0000000000004028
Thomalla, G. J. et al. Prediction of malignant middle cerebral artery infarction by early perfusion- and diffusion-weighted magnetic resonance imaging. Stroke 34(8), 1892–9 (2003).
pubmed: 12855829 doi: 10.1161/01.STR.0000081985.44625.B6
Sims, J. R. et al. ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 72(24), 2104–10 (2009).
pubmed: 19528517 pmcid: 2697964 doi: 10.1212/WNL.0b013e3181aa5329

Auteurs

Jack E Pohlmann (JE)

Department of Neurology, Boston Medical Center, 1 Boston Medical Center PI, Boston, MA, 02118, USA.
Department of Epidemiology, School of Public Health, Boston University, 715 Albany St, Boston, MA, 02118, USA.

Ivy So Yeon Kim (ISY)

Department of Neurology, Boston Medical Center, 1 Boston Medical Center PI, Boston, MA, 02118, USA.

Benjamin Brush (B)

Department of Neurology, NYU Langone Medical Center, 550 1st Ave, New York, NY, 10016, USA.

Krishna M Sambhu (KM)

Department of Neurology, Boston University School of Medicine, Chobanian and Avedisian School of Medicine, 85 E Concord St., Suite 1116, Boston, MA, 02118, USA.

Lucas Conti (L)

Department of Neurology, Boston University School of Medicine, Chobanian and Avedisian School of Medicine, 85 E Concord St., Suite 1116, Boston, MA, 02118, USA.

Hanife Saglam (H)

Department of Neurology, Brigham & Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA, 02115, USA.

Katie Milos (K)

Department of Neurology, Boston Medical Center, 1 Boston Medical Center PI, Boston, MA, 02118, USA.

Lillian Yu (L)

Department of Neurology, Boston Medical Center, 1 Boston Medical Center PI, Boston, MA, 02118, USA.

Michael F M Cronin (MFM)

Department of Neurology, Boston University School of Medicine, Chobanian and Avedisian School of Medicine, 85 E Concord St., Suite 1116, Boston, MA, 02118, USA.

Oluwafemi Balogun (O)

Department of Neurology, Boston Medical Center, 1 Boston Medical Center PI, Boston, MA, 02118, USA.

Stefanos Chatzidakis (S)

Department of Neurology, Brigham & Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA, 02115, USA.

Yihan Zhang (Y)

Department of Neurology, Boston Medical Center, 1 Boston Medical Center PI, Boston, MA, 02118, USA.

Ludovic Trinquart (L)

Department of Epidemiology, School of Public Health, Boston University, 715 Albany St, Boston, MA, 02118, USA.
Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington St, Boston, MA, 02111, USA.
Tufts Clinical and Translational Science Institute, Tufts University, 419 Boston, Ave, Medford, MA, 02155, USA.

Qiuxi Huang (Q)

Department of Epidemiology, School of Public Health, Boston University, 715 Albany St, Boston, MA, 02118, USA.

Stelios M Smirnakis (SM)

Department of Neurology, Brigham & Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA, 02115, USA.
Department of Neurology, Jamaica Plain Veterans Administration Medical Center, 150 S Huntington Ave, Boston, MA, 02130, USA.

Emelia J Benjamin (EJ)

Department of Epidemiology, School of Public Health, Boston University, 715 Albany St, Boston, MA, 02118, USA.
Department of Cardiology, Boston Medical Center and Boston University Chobanian and Avedisian School of Medicine, 85 E Concord St, Boston, MA, 02118, USA.

Josée Dupuis (J)

Department of Epidemiology, School of Public Health, Boston University, 715 Albany St, Boston, MA, 02118, USA.
Department of Epidemiology, Biostatistics and Occupational Health, McGill University, 2001 McGill College, Montreal, QC, Canada.

David M Greer (DM)

Department of Neurology, Boston Medical Center, 1 Boston Medical Center PI, Boston, MA, 02118, USA.
Department of Neurology, Boston University School of Medicine, Chobanian and Avedisian School of Medicine, 85 E Concord St., Suite 1116, Boston, MA, 02118, USA.

Charlene J Ong (CJ)

Department of Neurology, Boston Medical Center, 1 Boston Medical Center PI, Boston, MA, 02118, USA. cjong@bu.edu.
Department of Neurology, Boston University School of Medicine, Chobanian and Avedisian School of Medicine, 85 E Concord St., Suite 1116, Boston, MA, 02118, USA. cjong@bu.edu.
Department of Neurology, Brigham & Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA, 02115, USA. cjong@bu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH